Scholarlink

<p>A screening of commercial dog and cat foods revealed considerable variation in metabolite profiles across feed categories, with standard feeds generally showing higher concentrations of <i>Fusarium</i> metabolites, phytoestrogens, and plant metabolites than specialized senior or intestinal diets. Concentrations of aflatoxin B1 (AFB1), deoxynivalenol (DON) DON, zearalenone (ZEN), ochratoxin A (OTA), fumonisin B1 + 2 (FB1 + FB2), and T-2/HT-2 toxins remained below existing guidance values and maximum limits. In vitro assays using peripheral blood mononuclear cells (PBMCs) from dogs and cats demonstrated marked interspecies differences in mycotoxin sensitivity. Feline PBMCs were more susceptible to proliferation inhibition by DON and especially ZEN than canine PBMCs, consistent with known species-specific differences in xenobiotic metabolism. The potency ranking of tested compounds in dogs was in line with reports from other species, with T-2 toxin showing the highest cytotoxicity (EC50 &lt; 0.1 µM). Analysis of feed and blood samples indicated that systemic exposure to DON and ZEN under practical feeding conditions was several orders of magnitude below in vitro EC50 values, suggesting limited direct cytotoxic risk. Nonetheless, the presence of multiple mycotoxins in all feed categories underscores the need for continued surveillance and further studies linking feed composition, toxin occurrence, and toxicological thresholds to better inform companion animal health risk assessments.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

In vitro immunotoxicity of important mycotoxins detected in commercial dry dog and cat food in relation to internal exposure

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月18日

查看全文
  • Sven Dänicke,
  • Susanne Kersten,
  • Janine Saltzmann,
  • Nicola Mickenautsch,
  • Michael Sulyok,
  • Dian Schatzmayr,
  • Barbara Doupovec,
  • Nadine Paßlack

摘要

A screening of commercial dog and cat foods revealed considerable variation in metabolite profiles across feed categories, with standard feeds generally showing higher concentrations of Fusarium metabolites, phytoestrogens, and plant metabolites than specialized senior or intestinal diets. Concentrations of aflatoxin B1 (AFB1), deoxynivalenol (DON) DON, zearalenone (ZEN), ochratoxin A (OTA), fumonisin B1 + 2 (FB1 + FB2), and T-2/HT-2 toxins remained below existing guidance values and maximum limits. In vitro assays using peripheral blood mononuclear cells (PBMCs) from dogs and cats demonstrated marked interspecies differences in mycotoxin sensitivity. Feline PBMCs were more susceptible to proliferation inhibition by DON and especially ZEN than canine PBMCs, consistent with known species-specific differences in xenobiotic metabolism. The potency ranking of tested compounds in dogs was in line with reports from other species, with T-2 toxin showing the highest cytotoxicity (EC50 < 0.1 µM). Analysis of feed and blood samples indicated that systemic exposure to DON and ZEN under practical feeding conditions was several orders of magnitude below in vitro EC50 values, suggesting limited direct cytotoxic risk. Nonetheless, the presence of multiple mycotoxins in all feed categories underscores the need for continued surveillance and further studies linking feed composition, toxin occurrence, and toxicological thresholds to better inform companion animal health risk assessments.